Frontiers in Oncology (Dec 2023)
Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
Abstract
No abstracts available.Keywords
Frontiers in Oncology (Dec 2023)